Up to 30% off — ends 7 Aug

ONLY00h00m00s

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Thomas Dick

University Name

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

How do I reach out?

Meet Kite AI

Contact this professor

Research Interests

Pharmacology

Microbiology

Antimicrobial Research

Antibiotic Therapy

Antibiotic Resistance

Antifungal Pharmacology

Organophosphorus Chemistry

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Collaborators5

Mei Lin Go

National University of Singapore (NUS)

mercedes gonzalez-juarrero

Colorado State University

UNITED STATES

Adrian Richter

Martin Luther University Halle-Wittenberg

Dereje Abate Negatu

Hackensack University Medical Center

UNITED STATES

Volker Müller

Full Professor

Goethe University Frankfurt

How do I reach out?

Meet Kite AI

Thomas Dick

Professor

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles20

Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease

Next-generation rifamycins for the treatment of mycobacterial infections.

Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally.

Durlobactam to boost the clinical utility of standard of care β-lactams against Mycobacterium abscessus lung disease

Polymorphism of an Nα-Aroyl-N-Aryl-Phenylalanine Amide: An X-ray and Electron Diffraction Study

Broad-Spectrum In Vitro Activity of Nα-Aroyl-N-Aryl-Phenylalanine Amides against Non-Tuberculous Mycobacteria and Comparative Analysis of RNA Polymerases

Synthesis and in vitro Metabolic Stability of Sterically Shielded Antimycobacterial Phenylalanine Amides

Toward better cures for Mycobacterium abscessus lung disease

Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of Mycobacterium abscessus

Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease

ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant M. abscessus in caseum surrogate

Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycins

Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus

Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections

PROTAC antibiotics: the time is now

In Vitro Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessus

Redox Cycling Dioxonaphthoimidazoliums Disrupt Iron Homeostasis in Mycobacterium bovis Bacillus Calmette-Guérin

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro

Structural Elements Involved in ATP Hydrolysis Inhibition and ATP Synthesis of Tuberculosis and Nontuberculous Mycobacterial F-ATP Synthase Decipher New Targets for Inhibitors

Why Matter Matters: Fast-Tracking Mycobacterium abscessus Drug Discovery

Collaborators5

Mei Lin Go

mercedes gonzalez-juarrero

Adrian Richter

Dereje Abate Negatu

Volker Müller

How do I reach out?